PMN
ProMIS Neurosciences, Inc.
There isn't enough reported data to score PMN yet.
PMN Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Unavailable | |
| Unavailable |
PMN's revenue is currently strong, but its profitability is under pressure. There isn't enough data to rate its cash flow and balance sheet.
PMN PE Valuation
PMN has no meaningful PE right now: it lost money over the past year.
PMN Forward outlook
There aren't enough analyst estimates for PMN to show an outlook.
PMN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$8.89 | +$9.81 |
| Q2 2026 | -$14.00 | -$9.05 |
| Q1 2026 | -$19.97 | -$19.02 |
| Q4 2025 | -$23.96 | -$23.51 |
| Q3 2023 | -$51.24 | -$7.24 |
| Q2 2023 | -$67.74 | -$40.43 |
| Q1 2023 | -$70.49 | -$51.86 |
| Q4 2022 | -$62.39 | -$22.63 |
PMN is still losing money, but far less than before: $8.89 per share over the past year, against $70.49 at its worst in early 2023.
PMN Quarterly Revenue
PMN's revenue is growing: $3,612 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2022 | -95778% | N/A |
| Q4 2021 | -123523% | N/A |
| Q3 2021 | -40368% | N/A |
| Q2 2020 | 105445% | N/A |
| Q4 2019 | -193205% | N/A |
PMN's operating margin was −95778% last quarter, up 97427 points from the same quarter a year ago.
PMN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$9.4M | +$678.5K |
| Q2 2026 | -$10.4M | -$6.5M |
| Q1 2026 | -$12.4M | -$7.5M |
| Q4 2025 | -$9.3M | -$566.9K |
| Q3 2025 | -$10.1M | -$3.4M |
| Q2 2025 | -$3.9M | -$2.3M |
| Q1 2025 | -$4.9M | +$5.4M |
| Q4 2022 | -$4.6M | -$485.3K |
PMN has burned cash in almost every quarter: −$41M over the past year, against −$28M the year before.
PMN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +974 shares |
| 1 year | +368% | +7.2M shares |
| 3 years | +2564% | +8.8M shares |
| 5 years | +4383% | +8.9M shares |
| Available history | +5146% | +9M shares |
PMN has 9M diluted shares, up 368% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
PMN Net Leverage
PMN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PMN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.4 | Neutral |
| Stochastic | 5.5 | Oversold |
PMN's weekly RSI is 30 (neutral) and its Stochastic is 5 (oversold).
PMN PE vs Healthcare Sector
PMN has no meaningful PE right now: it lost money over the past year.
PMN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.21 | 52% below |
| 20 week MA | $11.2 | 69% below |
| 50 week MA | $11.8 | 70% below |
| 100 week MA | $13.6 | 74% below |
| 200 week MA | $38.6 | 91% below |
PMN is in a downtrend: it's below all five of its weekly moving averages, and 91% below its 200-week average.
PMN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $195.0 | $90.0 | -54% |
| 2021 | $90.0 | $165.0 | +83% |
| 2022 | $165.0 | $119.3 | -28% |
| 2023 | $119.3 | $28.8 | -76% |
| 2024 | $28.8 | $22.5 | -22% |
| 2025 | $22.5 | $7.66 | -66% |
| 2026 YTD | $7.66 | $3.48 | -55% |
PMN has finished four years in a row lower, and it's down 55% so far in 2026.